We would love to hear your thoughts about our site and services, please take our survey here.
LeddahJack,
Seems a few state the initial listing price of at least $4
See doc as of March 2021 (https://listingcenter.nasdaq.com/assets/initialguide.pdf)
But all mention
“ After the initial listing, if a stock's average closing price over any 30 consecutive trading days falls below $1, the stock is subject to delisting from the NYSE. This average closing price equals the sum of 30 consecutive closing prices, divided by 30. A closing price is the last trading price of a trading day”
New Proactive Vid:
https://youtu.be/taCQUAJwjg4
Just had a look, seems one person driven crazy by TILS posting to themselves pretty much
RokerP, you’re right. Ignore my last message.
RokerP
They did:
https://www.lse.co.uk/rns/TILS/accustem-update-x7enkf0upxj8czf.html
Denny, highly doubt the company that created a 40 page research note and quoted a price of $7.50 is posting fake news.
Recent article on Accustem:
https://scr.zacks.com/news/news-details/2021/TLSA-Accustem-Converging-on-NASDAQ/default.aspx
Bluebelly, not sure a single person on this board has guessed right with TILS over the last 6-9 months.
No bad news and so much great news and we are here sub £1 yet again. Every rise over the £1 get suppressed rather quickly. How long do people need to accumulate? Especially with such small free float
Level pegging on price now. $2.78 around 101p
Baffling day today
Being yanked down now. From morning lows to day high up 10% to then 9% down. Oh the games
Another patent granted it seems:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10973773.PN.&OS=PN/10973773&RS=PN/10973773
Original RNS
"It is intended that Accustem will seek admission to the standard segment of the Official List and admission to trading on the London Stock Exchange plc by way of an IPO in late Q4 2020 ("Accustem Admission") and POTENTIALLY a dual listing on NASDAQ in 2021."
I guess today is a confirmation of the dual listing and removing doubt of the potential/want to dual list
Last few weeks noticed lots of 10k & 25k sells going through. Back ground seller or MM's stemming price. Could be wrong, but been noticing this trend. IMO
A whole host of news was due in Q2 for many Phase 2 trial starts as well as top end data due last Q for Covid trial and well any news re Accustem listing.
yes you're late
Couldn’t agree more. No toxicity, shows promise. No adverse side effects even though a small subset and potentially massive upsides. Nothing to lose and all to gain. I’d throw the kitchen sink to help save the people of Brazil if I was the government and I’d heard of positive trials within the country. Very sad indeed :(
Yet more need for Foralumab. Tiziana need to start turning the cogs quicker to help save lives
https://www.theglobeandmail.com/canada/article-drug-critical-to-covid-19-patients-being-rationed-in-ontario/
MOG14 couldn’t agree more.
Since this time last year TILS is in a much stronger positions and pipeline trials still on track (apart from few delays)
Overall so far they have done and achieved what they said they would do. Successful trials, raised capital, added highly experienced members to the team with successful track records (Dr Neil Graham & Dr Adams)
Accustem process has been a bit of a ****-up but will come good.
Stronger the whole package gets the lower the price goes.....
GLA. Enjoy the long weekend
haha, BMO3 is back!
Great news today and much more to come I feel. Now is just the start hopefully. Much better volume too, nice to see life in TILS still exists
Unfortunately the board not surprisingly got clogged up with he said she said dribble or those posting new capital lettered SUBJECT HEADERS every few min. You know who who are.
Preferred it last week when it was 20 posts a day.
To the new investors welcome. Don’t be fooled on here by those with an certified profile badge or “lots of posts”. Usually means an agenda.
To the rest of the genuine investors, good luck.